Just like carcinogenic, mutagenic and reprotoxic substances, endocrine disruptors are substances of very high concern. These new measures mark a crucial step in ensuring a safe working environment and reducing the potential health risks associated with exposure to these substances.
Background: endocrine disrupting substances in the workplace
Endocrine disrupting substances, also known as endocrine disruptors, can have a negative impact on the human body's hormonal system. These substances are found in various industrial processes, chemical substances and materials used in the workplace. Workers in sectors such as the chemical industry, agriculture and the production of consumer goods may be at risk of exposure to these harmful substances.
Key features of the new legislation:
- Limits and Monitoring: The legislation sets clear limits for the concentration of endocrine disrupting substances in the workplace. Employers are obliged to regularly monitor the concentrations of these substances and ensure that they remain within the legally established limits.
- Information and Training: Employers are now obliged to provide employees with information and training on the risks of endocrine disrupting substances, as well as the appropriate measures for prevention and protection. This includes the use of personal protective equipment and awareness of potential exposure sources.
- Replacement Policy: The legislation encourages the use of alternative substances that are less harmful to health. Employers are encouraged to switch to less risky chemicals and processes wherever possible.
- Medical Supervision: For certain occupational groups with an increased risk of exposure, periodic medical examinations are mandatory. This allows potential health effects to be detected and treated early.
- Enforcement and Sanctions: The law provides for strict enforcement, with appropriate sanctions for employers who violate the regulations. This includes fines and possibly even legal prosecution in serious cases of negligence.
Impact and future perspectives:
The introduction of this legislation marks an important milestone in the protection of workers against the dangers of endocrine disrupting substances. It is not only a powerful step towards a safer working environment, but it also serves as a model for international standards in occupational safety.
As companies adapt to this new regulation, investments in research into safer alternatives and production processes are expected to increase. This would not only protect employees, but also provide an impetus for innovation in healthier and more sustainable working environments.
In the coming years, monitoring and evaluation of the implementation of this legislation will be essential to ensure that the intended objectives are achieved and that workers in various sectors actually benefit from the improved protection measures against endocrine disrupting substances.
Legislation
In the Belgian Official Gazette of 18 July 2023, the Royal Decree of 2 July 2023 establishing measures for the protection of workers against agents with endocrine disrupting properties was published. The Royal Decree entered into force on 28 July 2023.
By this Royal Decree, endocrine disruptors are included in the scope of title 2 of book VI of the code on well-being at work. This means that, with regard to the protection of workers, the same rules now apply to these substances as to carcinogenic, mutagenic and reprotoxic substances.
The legislator has chosen to include a list of endocrine disruptors in the code. Finally, endocrine disruptors are not yet included as such in the safety data sheets (SDS, in English MSDS). In the future, they will be included under the new ECHA hazard codes H380 (proven) and H381 (suspected), and in sections 2.3, 3.2 and 11.2.1 and/or 15.1.
Furthermore, this Royal Decree explicitly mentions endocrine disruptors in the provisions concerning maternity protection (title 5 of book X of the code) and protection of young people at work (title 3 of book X of the code). Pregnant women and their unborn children, and young people are particularly sensitive risk groups for exposure to these substances.
Source: Beswic.
